Skip to content

BETTER prevention and screening: Personalized clinical visits for adults

Building on Existing Tools To improvE cancer and chronic disease pRevention and screening in primary care for Wellness of cancer survIvorS and patiEnts: The BETTER WISE Project

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN21333761
Enrollment
1280
Registered
2016-12-19
Start date
2018-01-01
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer and chronic disease Cancer

Interventions

Current interventions (as of 18/12/2017): Participating primary care physicians will be randomized to have their patients in the intervention group or to a wait-list control group. The physician is de

Sponsors

University of Alberta
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 40-65 years of age 2. Men and women 3. Able to give written informed consent 4. Cancer survivors who are low risk breast and/or colorectal and/or prostate cancer survivors 5. Patients without a personal history of breast, colorectal or prostate cancer 6. Patients on whom the researchers can obtain access to their medical records for the previous three years 7. Patients who are able to attend in-person preventions visits at their primary care site 8. Patients who are not receiving active treatment (i.e., systemic and/or radiation therapy) for cancer

Exclusion criteria

Exclusion criteria: 1. Unable to give written informed consent for reasons of language, literacy, or competence 2. Unable to access their medical history for the previous three years 3. Receiving active treatment for cancer (i.e., systemic and/or radiation therapy) *Prophylactic or hormone treatments (e.g., aromatase inhibitors) are not exclusion criteria. Physicians may request that a particular patient not be invited and the rationale for exclusion will be captured (e.g. patient too frail)

Design outcomes

Primary

MeasureTime frame
Proportion of cancer and chronic disease prevention and screening (CCDPS) actions for which the patient was eligible at baseline that are met (according to pre-defined targets) at 12-month follow-up.

Secondary

MeasureTime frame
1. Proportion of patients meeting the evidence-based targets will be measured by tracking specific cancer and chronic disease prevention and screening actions (e.g. mammograms completed, alcohol consumption reduced, screening for poverty) longitudinally at 6, 12, 18 and 24 months 2. Number of targeted cancer and chronic disease prevention and screening actions that patients randomized to the intervention group were deemed eligible to improve at baseline that are met (according to pre-defined targets) at 24-month follow-up

Countries

Canada

Contacts

Public ContactCarolina Aguilar
carolina.aguilar@ualberta.ca+1 780 248 2021

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 23, 2026